{
  "docId": "019de074-c961-75ce-9ec9-a463e48376df",
  "docSlug": "54709ba209601bcbd02096c2ee161b23",
  "documentTitle": "AbCellera | Results Presentation Deck | 18 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 18,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a molecular visualization of an antibody to illustrate the two functional arms of a T-cell engager.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-c961-75ce-9ec9-a463e48376df/5",
  "deckHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df",
  "deckJsonHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df.json",
  "deckAnchorHref": "/decks/019de074-c961-75ce-9ec9-a463e48376df#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.75,
        "y": 0.64
      },
      "kind": "callout",
      "text": "only targeting cancer cells. For the arm that binds to the cancer cell, the goal is to target only cancer cells, and not healthy cells.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b50f44fa-b834-43dc-96f9-f422022687be",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.105,
        "y": 0.64
      },
      "kind": "callout",
      "text": "controlling how T cells are activated. For the arm that binds to the T cell, the goal is to balance potency & cytokine release.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f378b275-a66e-4503-97bc-10be4080f874",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.4,
        "x": 0.3,
        "y": 0.45
      },
      "kind": "image",
      "text": "Molecular structure of a T-cell engager antibody",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "544e667c-d6fb-42a3-8c7b-14628a0deead",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.36,
        "x": 0.585,
        "y": 0.218
      },
      "kind": "paragraph",
      "text": "T-cell engagers (TCEs) are antibodies with 2 arms that are designed to simultaneously bind to cancer cells and specific immune cells called T cells. TCEs work by bringing T cells and cancer cells together and stimulating the T cells to kill the cancer cells.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9be0e79f-cac9-43a4-bc62-1ad07def845b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.105,
        "y": 0.16
      },
      "kind": "title",
      "text": "Solving key challenges in developing T-cell engager cancer treatments.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6f548a26-825d-46ff-95e4-25cc744b65a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.105,
        "y": 0.075
      },
      "kind": "title",
      "text": "TECHNOLOGY DEVELOPMENT. T-Cell Engager Platform",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd806e03-db17-4b1c-ab1c-3127f8ee38e8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Call to action",
      "slug": "call-to-action",
      "agent": null,
      "layer": "slide",
      "matchId": "239fc06c-41f0-4acc-b4e4-3fee6bc8597c",
      "evidence": "callout/primary: only targeting cancer cells.",
      "confidence": 0.5
    },
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "684db4c6-d949-4474-9c4c-00ee2b99d1e4",
      "evidence": "paragraph/paragraph: T-cell engagers (TCEs) are antibodies with 2 arms that are designed to simultaneously bind to cancer cells and specific immune cells called T cells.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "8d27ef3c-91db-4569-9674-04be9eb8a0cd",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "The problem statement is presented on page 5.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "e0060ecf-c7c5-414e-8f44-fa48bc49cac9",
      "evidence": "The problem statement and thesis headline suggest a cost of inaction.",
      "position": 0,
      "objective": "What are the costs of not solving the challenge of developing T-cell engager cancer treatments?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 7,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "ef4b542e-5e1c-4ccf-8641-084f7bec094c",
      "evidence": "The executive summary and key takeaways suggest a golden circle loop.",
      "position": 1,
      "objective": "Why is AbCellera's approach to T-cell engagers important?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}